Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
WTX101-201: A Phase 2, Multi-centre, Open-label, Study to Evaluate the Efficacy and Safety of TWX101 Administered for 24 Weeks in Newly Diagnosed Wilson Disease Patients Aged 18 and Older
Bega, Danny
(PD/PI)
Neurology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
1/21/15
→
1/21/18
Funding
Agility Clinical
(WTX101-201)
Wilson Therapeutics AB
(WTX101-201)
View all
View less